Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.53 |
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.51 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.47 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | DRD2 | P14416 | 3/20 | 0.44 |
| ▸ | DRD3 | P35462 | 2/20 | 0.44 |
| ▸ | PNMT | P11086 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | MAOA | P21397 | 2/20 | 0.42 |
| ▸ | HTR2C | P28335 | 2/20 | 0.42 |
| ▸ | HTR2B | P41595 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31441011 | 1.00 | SMN1; SMN2 (0.53) | SMN1; SMN2MAPTHPGDALDH1A1NPC1 | |
| SCHEMBL17242315 | 0.92 | TRPA1 (0.51) | SMN1; SMN2MAPTHPGDALDH1A1NPC1 | |
| SCHEMBL30950987 | 0.90 | PNMT (0.52) | TRPA1PDK2DRD2DRD3PNMT | |
| SCHEMBL6014131 | 0.90 | PNMT (0.52) | TRPA1PDK2DRD2DRD3PNMT | |
| SCHEMBL11678763 | 0.88 | PNMT (0.47) | SMN1; SMN2MAPTHPGDALDH1A1NPC1 | |
| SCHEMBL28246117 | 0.86 | PDK2 (0.50) | SMN1; SMN2MAPTHPGDALDH1A1NPC1 | |
| SCHEMBL10052973 | 0.83 | TRPA1 (0.44) | SMN1; SMN2MAPTHPGDALDH1A1NPC1 | |
| SCHEMBL31739245 | 0.82 | TSHR (0.47) | SMN1; SMN2MAPTHPGDALDH1A1NPC1 | |
| SCHEMBL11676256 | 0.81 | PNMT (0.47) | ALDH1A1TRPA1DRD2DRD3PNMT | |
| SCHEMBL739759 | 0.81 | SMN1; SMN2 (0.53) | SMN1; SMN2MAPTHPGDALDH1A1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260150499-A1 | Organic Compounds and Electroluminescent Device Comprising the Same | P&H TECH CO., LTD (KR) | 2026-05-28 | — | — | US | disclosed |
| US-20260093180-A1 | METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE AND COMPOSITION FOR FILM FORMATION | JSR CORPORATION (JP) | 2026-04-02 | — | — | US | disclosed |
| US-20250346585-A1 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | ALEXION PHARMACEUTICALS, INC. (US) | 2025-11-13 | — | — | US | disclosed |
| CN-119219454-A | Method for preparing aromatic nitrile compound by photoinitiating nitroarene denitration cyanation | 武汉光化学技术研究院 | 2024-12-31 | — | — | CN | disclosed |
| CN-117903077-B | Dihydrooxadiazinone compound and application thereof | 上海超阳药业有限公司 | 2024-09-03 | — | — | CN | disclosed |
| WO-2024136541-A1 | ORGANIC LUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | 솔루스첨단소재 주식회사 | 2024-06-27 | — | — | WO | disclosed |
| CN-117903077-A | Dihydrooxadiazinon compound and application thereof | 上海超阳药业有限公司 | 2024-04-19 | — | — | CN | disclosed |
| WO-2024034311-A1 | SEMICONDUCTOR SUBSTRATE PRODUCTION METHOD AND FILM FORMING COMPOSITION | JSR株式会社 | 2024-02-15 | — | — | WO | disclosed |
| WO-2023183405-A2 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | ALEXION PHARMACEUTICALS, INC. (US) | 2023-09-28 | — | — | WO | disclosed |
| WO-2023183405-A2 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | ALEXION PHARMACEUTICALS, INC. (US) | 2023-09-28 | — | — | WO | disclosed |
| EP-1817392-A1 | FLUORESCENT DIKETOPYRROLOPYRROLES | Ciba Specialty Chemicals Holding Inc. (CH) | 2007-08-15 | — | — | EP | disclosed |
| WO-2006061343-A1 | FLUORESCENT DIKETOPYRROLOPYRROLES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-06-15 | — | — | WO | disclosed |
| EP-0400972-B1 | Fluorescent degree of cure monitors | MINNESOTA MINING & MFG (US) | 1996-07-03 | — | — | EP | disclosed |
| US-5182316-A | Forming a UV-detectable fluorophore in a mixture of hydride containing silicone, unsaturated silicone, cationically sensitive compound and a latent dibenzofulvene | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1993-01-26 | — | — | US | disclosed |
| US-5118559-A | Dibenzofulvene compound | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1992-06-02 | — | — | US | disclosed |
| US-5047444-A | Hydrosilatable polysiloxanes, unsaturated compounds and a dibenzofulvene chromogen; coatings | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1991-09-10 | — | — | US | disclosed |
| EP-0400972-A2 | Fluorescent degree of cure monitors | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1990-12-05 | — | — | EP | disclosed |
| US-4656233-A | \"Living\" polymers and chain transfer-regulated polymerization process | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-04-07 | — | — | US | disclosed |
| EP-0186330-A1 | \"Living\" polymers and chain transfer-regulated polymerization process | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-07-02 | — | — | EP | disclosed |
| US-4189323-A | Radiation-sensitive copying composition | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260093180-A1 | METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE AND COMPOSITION FOR FILM FORMATION | SMC4, TYR, SMC2 | SMN1; SMN2 1676/4885MAPT 1281/4885HPGD 4696/4885 |
| US-20250346585-A1 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | C5, C1S, C9 | SMN1; SMN2 266/4885MAPT 1464/4885HPGD 1644/4885 |
| US-20260150499-A1 | Organic Compounds and Electroluminescent Device Comprising the Same | CRY2, NOX1, NOX4 | SMN1; SMN2 1086/4885MAPT 3974/4885HPGD 3739/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.